Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

Q Liu, C Qin, M Liu, J Liu - Infectious diseases of poverty, 2021 - mednexus.org
Background: To date, coronavirus disease 2019 (COVID-19) becomes increasingly fierce
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …

[HTML][HTML] Accelerated COVID-19 vaccine development: milestones, lessons, and prospects

K Bok, S Sitar, BS Graham, JR Mascola - Immunity, 2021 - cell.com
The development of effective vaccines to combat infectious diseases is a complex multi-year
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …

[HTML][HTML] Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

SY Tartof, JM Slezak, H Fischer, V Hong, BK Ackerson… - The Lancet, 2021 - thelancet.com
Background Vaccine effectiveness studies have not differentiated the effect of the delta (B.
1.617. 2) variant and potential waning immunity in observed reductions in effectiveness …

SARS-CoV-2 vaccine protection and deaths among US veterans during 2021

BA Cohn, PM Cirillo, CC Murphy, NY Krigbaum… - Science, 2022 - science.org
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine
effectiveness against infection (VE-I) and death (VE-D) by vaccine type in 780,225 veterans …

Public health impact of covid-19 vaccines in the US: observational study

AB Suthar, J Wang, V Seffren, RE Wiegand, S Griffing… - Bmj, 2022 - bmj.com
Objective To evaluate the impact of vaccine scale-up on population level covid-19 mortality
and incidence in the United States. Design Observational study. Setting US county level …

[HTML][HTML] Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

A Cho, F Muecksch, D Schaefer-Babajew, Z Wang… - Nature, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell
responses that continue to evolve for at least a year. During that time, memory B cells …

[HTML][HTML] Effectiveness of mRNA Covid-19 vaccine among US health care personnel

T Pilishvili, R Gierke, KE Fleming-Dutra… - … England Journal of …, 2021 - Mass Medical Soc
Background The prioritization of US health care personnel for early receipt of messenger
RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS …

[HTML][HTML] Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

KB Pouwels, E Pritchard, PC Matthews, N Stoesser… - Nature medicine, 2021 - nature.com
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …

[HTML][HTML] New COVID-19 cases and hospitalizations among adults, by vaccination status—New York, May 3–July 25, 2021

ES Rosenberg - MMWR. Morbidity and mortality weekly report, 2021 - cdc.gov
During May 3–July 25, 2021, the overall age-adjusted vaccine effectiveness against
hospitalization in New York was relatively stable (91.9%–95.3%). The overall age-adjusted …

Estimated number of COVID-19 infections, hospitalizations, and deaths prevented among vaccinated persons in the US, December 2020 to September 2021

MK Steele, A Couture, C Reed, D Iuliano… - JAMA Network …, 2022 - jamanetwork.com
Importance The number of SARS-CoV-2 infections and COVID-19–associated
hospitalizations and deaths prevented among vaccinated persons, independent of the effect …